News tagged with regimen
Landmark study confirms chemotherapy benefit in breast cancer patients
Chemotherapy generally improves survival in postmenopausal breast cancer patients, according to a landmark study led by Dr. Kathy Albain of Loyola University Health System.
Dec 11, 2009 |
not rated yet |
0
US approves second new hepatitis C drug
The US Food and Drug Administration on Monday approved Incivek to treat hepatitis C when taken along with the current two-drug regimen, marking the second such drug approval this month.
Medicine & Health / Medications
May 23, 2011 |
not rated yet |
0
US regulators approve new hepatitis C drug
US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.
Medicine & Health / Medications
May 14, 2011 |
not rated yet |
2
New treatment regimen shown effective against advanced ovarian cancer
Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards ...
Jun 06, 2010 |
not rated yet |
0
Combination treatment regimen not effective against advanced melanoma
The combination of two different chemotherapies and a previously approved treatment for kidney and liver cancers is not effective against advanced melanoma, according to results disclosed in an oral presentation today at ...
Jun 05, 2010 |
4 / 5 (1) |
0
Parents keep diabetic teens on track
Teenagers and "tweenagers" with type 1 diabetes have more trouble sticking to their treatment plan - thus raising their risk of blindness, kidney failure and heart disease - if their parents become increasingly lax about ...
Medicine & Health / Diseases, Conditions, Syndromes
Apr 07, 2010 |
not rated yet |
0
New treatment option for latent tuberculosis
Patients who are infected with the latent form of tuberculosis (TB) show no symptoms and are not contagious, yet they pose the biggest challenge when it comes to controlling the disease. The latest study by Dr. Dick Menzies ...
Medicine & Health / Diseases, Conditions, Syndromes
Jan 22, 2009 |
5 / 5 (1) |
0
Facebook co-founder killing his own food: Fortune
Facebook co-founder Mark Zuckerberg has reportedly taken to eating only meat from animals he has killed in order to appreciate that a creature died so that he could live.
May 27, 2011 |
not rated yet |
4
Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
Using an accelerated, shorter course of radiation therapy for patients with advanced head and neck cancer allows doctors to reduce the amount of chemotherapy, thus reducing toxicity, according to a study presented at the ...
Feb 25, 2010 |
not rated yet |
0
Erlotinib dosing in lung cancer depends on smoking status
Although erlotinib is an approved second-line therapy for lung cancer, its management is complicated by side effects that get worse as the dose increases.
Jan 12, 2010 |
not rated yet |
0
Five tips for stress-free exams
(PhysOrg.com) -- It's exam time, and for many students that means long days, late nights and lots of coffee. It's easy to let the anxiety get to you, so what can you do to cope with exam tension?
Dec 16, 2009 |
5 / 5 (2) |
0
Combination antiretroviral therapy effective at reducing HIV resistance in mothers and babies
In a clinical trial investigating mother-to-child HIV transmission in South Africa published this week in PLoS Medicine, Neil Martinson (of the Perinatal HIV Research Unit, Soweto, South Africa) and colleagues find that a ...
Medicine & Health / HIV & AIDS
Oct 27, 2009 |
not rated yet |
0
Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks
New research led by Cindy Schwartz, MD, of Hasbro Children's Hospital has identified a new chemotherapy regimen for pediatric Hodgkin lymphoma (HL) patients. The new treatment enhances efficacy through dose-dense drug delivery ...
Jul 13, 2009 |
not rated yet |
0
Triple drug combination is promising option to treat metastatic HER2+ breast cancer
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
May 15, 2009 |
5 / 5 (1) |
0
